NO20060669L - Modafinilsammensetninger - Google Patents

Modafinilsammensetninger

Info

Publication number
NO20060669L
NO20060669L NO20060669A NO20060669A NO20060669L NO 20060669 L NO20060669 L NO 20060669L NO 20060669 A NO20060669 A NO 20060669A NO 20060669 A NO20060669 A NO 20060669A NO 20060669 L NO20060669 L NO 20060669L
Authority
NO
Norway
Prior art keywords
modulated
modafinil
enantiomerically
modafinilsammensetninger
solvates
Prior art date
Application number
NO20060669A
Other languages
Norwegian (no)
Inventor
Matthew Peterson
Orn Almarsson
Mark Oliveira
Magali Bourghol Hickey
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/660,202 external-priority patent/US7927613B2/en
Priority claimed from PCT/US2004/006288 external-priority patent/WO2004078163A2/en
Priority claimed from PCT/US2004/029013 external-priority patent/WO2005023198A2/en
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of NO20060669L publication Critical patent/NO20060669L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Abstract

Det blir fremstilt ko-krystaller og solvater av racemisk, enantiomert ren og enantiomert blandet modafinil, og flere viktige fysiske egenskaper blir modulert. Løselighet, oppløsning, biotilgjengelighet, doserespons og stabilitet til modafinil kan moduleres for å forbedre effektiviteten i farmasøytiske preparater.Co-crystals and solvates of racemic, enantiomerically pure and enantiomerically mixed modafinil are prepared, and several important physical properties are modulated. Solubility, resolution, bioavailability, dose response and stability to modafinil can be modulated to improve the efficacy of pharmaceutical preparations.

NO20060669A 2003-09-11 2006-02-10 Modafinilsammensetninger NO20060669L (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US10/660,202 US7927613B2 (en) 2002-02-15 2003-09-11 Pharmaceutical co-crystal compositions
US50820803P 2003-10-02 2003-10-02
US54275204P 2004-02-06 2004-02-06
PCT/US2004/006288 WO2004078163A2 (en) 2003-02-28 2004-02-26 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
US56041104P 2004-04-06 2004-04-06
US57341204P 2004-05-21 2004-05-21
US57917604P 2004-06-12 2004-06-12
US58199204P 2004-06-22 2004-06-22
US58675204P 2004-07-09 2004-07-09
US58823604P 2004-07-15 2004-07-15
PCT/US2004/029013 WO2005023198A2 (en) 2003-09-04 2004-09-04 Modafinil compositions

Publications (1)

Publication Number Publication Date
NO20060669L true NO20060669L (en) 2006-06-02

Family

ID=36763171

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060669A NO20060669L (en) 2003-09-11 2006-02-10 Modafinilsammensetninger

Country Status (4)

Country Link
EP (1) EP1670753A4 (en)
JP (1) JP4842819B2 (en)
IL (2) IL173575A0 (en)
NO (1) NO20060669L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6074142B2 (en) * 2009-02-26 2017-02-01 タール ファーマシューティカルズ，インコーポレイテッド Crystallization of pharmaceutical compounds
WO2013147072A1 (en) * 2012-03-29 2013-10-03 大鵬薬品工業株式会社 Cocrystal of 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexen-1-one

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593809B1 (en) * 1986-01-31 1988-07-22 Lafon Labor BENZHYDRYLSULFINYLACETAMIDE, PROCESS FOR PREPARATION AND THERAPEUTIC USE
KR100729292B1 (en) * 2000-07-27 2007-06-18 테바 파마슈티컬 인더스트리즈 리미티드 Crystalline and pure modafinil, and process of preparing the same
IL143106A (en) * 2001-05-13 2005-11-20 Chemagis Ltd Process for the preparation of diphenylmethylthioacetamide
FR2849029B1 (en) * 2002-12-20 2005-03-18 Lafon Labor PROCESS FOR THE PREPARATION AND CRYSTALLINE FORMS OF OPTICAL ENANTIOMERS OF MODAFINIL.
CA2514733A1 (en) * 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
JP4923182B2 (en) * 2003-02-28 2012-04-25 マクニール−ピーピーシー・インコーポレーテツド Celecoxib and nicotinamide co-crystal and pharmaceutical composition containing the co-crystal

Also Published As

Publication number Publication date
JP4842819B2 (en) 2011-12-21
IL173575A0 (en) 2006-07-05
JP2007513867A (en) 2007-05-31
EP1670753A2 (en) 2006-06-21
EP1670753A4 (en) 2008-01-02
IL199140A (en) 2012-07-31

Similar Documents

Publication Publication Date Title
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
WO2005023198A3 (en) Modafinil compositions
DE60132309D1 (en) AMIN DERIVATIVES FOR THE TREATMENT OF APOPTOSIS
NO20051966L (en) New pyrimidinamide derivatives and their use
SE0401971D0 (en) Piperidne derivatives
EA200602196A1 (en) DERIVATIVES OF PYRAZOL, COMPOSITIONS CONTAINING THESE CONNECTIONS AND METHODS OF APPLICATION
DK1299348T3 (en) Compounds and compositions for delivery of active agents
RS52169B (en) Stable laquinimod preparations
NO20050428L (en) Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and their use in the treatment of benign and malignant tumor diseases
NO20064934L (en) Process for the preparation of a solid pharmaceutical composition
NO20054787D0 (en) Indene derivatives as pharmaceuticals
DK1730147T3 (en) Substituted 1,4,8-triazaspiro [4.5] decan-2-one compounds for the treatment of obesity
MA27880A1 (en) TETRAHYDROCARBAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE
NO20072515L (en) 2-amido-4-phenyltnazole derivatives, preparation and therapeutic use thereof
SE0401970D0 (en) Novel compounds
DK1294747T3 (en) Synthetic Methods for Aplidine and New Antitumoral Derivatives, Methods for Preparing and Using Them
SE0402762D0 (en) Indazole sulphonamide derivatives
NO20034386L (en) Solid pharmaceutical composition comprising 4-cyano-trifluoro-3- (4-fluorophenylsulfonyl) -2-hydroxy-2-methylpropiono-m-toluidide and PVP
MEP20908A (en) Thienopyrazoles
DE60142913D1 (en) DRUG SOLUTIONS CONTAIN MODAFINIL COMPOUNDS
EA200501821A1 (en) PHARMACEUTICAL COMBINATION, CONTAINING MODAFINIL AND OTHER DRUG PREPARATION
ME00483B (en) Parenteral composition of paracetamol
SE0203303D0 (en) Novel Compounds
NO20060669L (en) Modafinilsammensetninger
NO20054417L (en) Process for the preparation of pharmaceutical preparations in the form of fibrate-containing tablets and the tablets thus prepared

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application